G. Kenneth Lloyd founded GKOL, Inc.
He is Chief Scientific Officer at BeyondSpring, Inc. Dr. Lloyd is also on the board of Verne Mendel Medical Corp.
In the past Dr. Lloyd was Chief Scientific Officer & Senior VP-Research at Nereus Pharmaceuticals, Inc., Chief Scientific Officer of Dalian Wanchun Biotechnology Co. Ltd., Research Director at A.E. Wyeth & Co., Vice President-Biology & Drug Discovery at Sibia Neurosciences, Inc., Assistant Vice President at Wyeth-Ayerst Research, Vice Director at Sanofi SA and Director at GKOL, Inc.
G. Kenneth Lloyd received a doctorate from the University of Toronto and a graduate degree and an undergraduate degree from McGill University.